A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia-Reference-Cited by-同舟云学术

A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia

Published:2004-07-03 Issue:10 Volume:12 Page:725-730
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Lalami Y.,Paesmans M.,Aoun M.,Munoz-Bermeo R.,Reuss K.,Cherifi S.,Alexopoulos C. G.,Klastersky J.

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-004-0658-6.pdf

Reference24 articles.

1. Bodey GP, Buckley M, Sathe Y et al (1966) Quantitative relationships between circulating leucocytes and infection in patients with acute leukemia. Ann Intern Med 64:328?339

2. Berghmans T, Paesmans M, Lafitte JJ et al (2002) Therapeutic use of granulocyte and granulocyte-macrophage-stimulating factors in febrile neutropenic cancer patients: systematic review of the literature with meta-analysis. Support. Care Cancer 10:181?188

3. Blay JY, Chauvin F, Le Cesne B et al (1996) Early lymphopenia after cytotoxic chemotherapy as risk factor for febrile neutropenia. J Clin Oncol 14:636?643

4. Chang J (2000) Chemotherapy dose reduction and delay in clinical practice: evaluating the risk to patient outcome in adjuvant chemotherapy for breast cancer. Eur J Cancer 36:S11?S14

5. Chouaid C, Bassinet L, Fuhrman C et al (1998) Routine use of granulocyte colony-stimulating factor is not cost-effective and does not increase patient comfort in the treatment of small cell lung cancer: an analysis using a markov model. J Clin Oncol 16:2700?2707

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prophylactic administration of mecapegfilgrastim after chemotherapy in patients with lymphoma;Annals of Palliative Medicine;2021-12

2. Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?;Cancers;2021-06-26

3. Utility of prophylactic antibiotics for preventing febrile neutropenia during cabazitaxel therapy for castration-resistant prostate cancer;Scientific Reports;2021-04-16

4. Febrile neutropenia hospitalization due to pegfilgrastim on-body injector failure compared to single-injection pegfilgrastim and daily injections with reference and biosimilar filgrastim: US cost simulation for lung cancer and non-Hodgkin lymphoma;Journal of Medical Economics;2019-09-03

5. Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study;Future Oncology;2019-03